TranscriptsUnited KingdomJul. 29, 2025 6:47 PM ETAstraZeneca PLC (AZN) Stock, AZNCF StockAZN, AZNCFSA Transcripts154.38K FollowersQ2: 2025-07-29 Earnings SummarySlidesEPS of $1.09 misses by $0.38 | Revenue of $14.46B (11.74% Y/Y) beats by $362.00MAstraZeneca PLC (NASDAQ:AZN) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ETCompany ParticipantsAndrew P. Barnett - Head of Investor RelationsAradhana Sarin - CFO & Executive DirectorDavid Fredrickson - Executive Vice-President of Oncology Haematology Business UnitIskra Reic - Executive Vice President of InternationalMarc Dunoyer - CEO of Alexion & Chief Strategy OfficerPascal Claude Roland Soriot - CEO & Executive DirectorRuud Dobber - Executive Vice-President of BioPharmaceuticals Business UnitSharon Barr - Executive Vice-President of BioPharmaceuticals R&DSusan Mary Galbraith - Executive Vice President of Oncology R&DConference Call ParticipantsGonzalo Artiach Castanon - Danske Bank A/S, Research DivisionJames Daniel Gordon - JPMorgan Chase & Co, Research DivisionLuisa Caroline Hector - Joh. Berenberg, Gossler & Co. KG, Research DivisionMatthew Weston - UBS Investment Bank, Research DivisionMichael Leuchten - Unidentified CompanyPeter Verdult - BNP Paribas Exane, Research DivisionRajan Sharma - Goldman Sachs Group, Inc., Research DivisionSachin Jain - BofA Securities, Research DivisionSarita Kapila - Morgan Stanley, Research DivisionSeamus Christopher Fernandez - Guggenheim Securities, LLC, Research DivisionOperatorGood afternoon, and welcome to AstraZeneca's H1 and Q2 2025 webinar for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement. The company intends to utilize the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca. Although we believe our expectations are based on reasonable assumptions, by their very nature, forward-looking statements involve risks and uncertainties and may be influenced by factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements.Any forward-looking statements made on this callRead more current AZN analysis and newsView all earnings call transcriptsComments